{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:18:21Z","timestamp":1790068701099,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-024-03972-w","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T04:30:47Z","timestamp":1708489847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Safety of\u00a0Ablative\u00a0Fractional\u00a0Laser in Melasma: A Meta-analysis and Systematic Review"],"prefix":"10.1007","volume":"39","author":[{"given":"Shasha","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"issue":"6","key":"3972_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/exd.13844","volume":"28","author":"SH Kwon","year":"2019","unstructured":"Kwon SH, Na JI, Choi JY et al (2019) Melasma: Updates and perspectives. Experimental Dermatol 28(6):704\u20138. https:\/\/doi.org\/10.1111\/exd.13844","journal-title":"Experimental Dermatol"},{"issue":"Suppl 1","key":"3972_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.12049","volume":"27","author":"T Passeron","year":"2013","unstructured":"Passeron T (2013) Melasma pathogenesis and influencing factors - an overview of the latest research. J Eur Acad Dermatol Venereol 27(Suppl 1):5\u20136. https:\/\/doi.org\/10.1111\/jdv.12049","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"3972_CR3","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1111\/jocd.14382","volume":"20","author":"O Artzi","year":"2021","unstructured":"Artzi O, Horovitz T, Bar-Ilan E et al (2021) The pathogenesis of melasma and implications for treatment. J Cosmet Dermatol 20(11):3432\u201345. https:\/\/doi.org\/10.1111\/jocd.14382","journal-title":"J Cosmet Dermatol"},{"key":"3972_CR4","doi-asserted-by":"publisher","unstructured":"Pi\u0119towska Z, Nowicka D, Szepietowski JC (2022) Understanding melasma-how can pharmacology and cosmetology procedures and prevention help to achieve optimal treatment results? A narrative review. Int J Environ Res Public Health 19(19):12084. https:\/\/doi.org\/10.3390\/ijerph191912084","DOI":"10.3390\/ijerph191912084"},{"issue":"9","key":"3972_CR5","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s13555-022-00779-x","volume":"12","author":"ACC Esp\u00f3sito","year":"2022","unstructured":"Esp\u00f3sito ACC, Cassiano DP, da Silva CN et al (2022) Update on Melasma-Part I: Pathogenesis. Dermatol Ther (Heidelb). 12(9):1967\u201388. https:\/\/doi.org\/10.1007\/s13555-022-00779-x","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"9","key":"3972_CR6","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s13555-022-00780-4","volume":"12","author":"DP Cassiano","year":"2022","unstructured":"Cassiano DP, Esp\u00f3sito ACC, da Silva CN et al (2022) Update on Melasma-Part II: Treatment. Dermatol Ther (Heidelb). 12(9):1989\u20132012. https:\/\/doi.org\/10.1007\/s13555-022-00780-4","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"4","key":"3972_CR7","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s10103-022-03514-2","volume":"37","author":"D Lai","year":"2022","unstructured":"Lai D, Zhou S, Cheng S et al (2022) Laser therapy in the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci. 37(4):2099\u2013110. https:\/\/doi.org\/10.1007\/s10103-022-03514-2","journal-title":"Lasers Med Sci."},{"issue":"2","key":"3972_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1590\/s0365-05962013000200009","volume":"88","author":"OO Morais","year":"2013","unstructured":"Morais OO, Lemos \u00c9F, Sousa MC et al (2013) The use of ablative lasers in the treatment of facial melasma. An Bras Dermatol. 88(2):238\u201342. https:\/\/doi.org\/10.1590\/s0365-05962013000200009","journal-title":"An Bras Dermatol."},{"issue":"12","key":"3972_CR9","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/pharmaceutics14122738","volume":"14","author":"WHS Ng","year":"2022","unstructured":"Ng WHS, Smith SD (2022) Laser-assisted drug delivery: a systematic review of safety and adverse events. Pharmaceutics 14(12):2738. https:\/\/doi.org\/10.3390\/pharmaceutics14122738","journal-title":"Pharmaceutics"},{"key":"3972_CR10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj. 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"Bmj."},{"issue":"4","key":"3972_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s40257-014-0080-x","volume":"15","author":"NY Jalaly","year":"2014","unstructured":"Jalaly NY, Valizadeh N, Barikbin B et al (2014) Low-power fractional CO2 laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol 15(4):357\u201363. https:\/\/doi.org\/10.1007\/s40257-014-0080-x","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"3972_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/lsm.23032","volume":"51","author":"SO Tawfic","year":"2019","unstructured":"Tawfic SO, Abdel Halim DM, Albarbary A et al (2019) Assessment of combined fractional CO(2) and tranexamic acid in melasma treatment. Lasers Surg Med 51(1):27\u201333. https:\/\/doi.org\/10.1002\/lsm.23032","journal-title":"Lasers Surg Med"},{"issue":"2","key":"3972_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijd.IJD_240_17","volume":"64","author":"S Nourmohammadi Abadchi","year":"2019","unstructured":"Nourmohammadi Abadchi S, Fatemi Naeini F, Beheshtian E (2019) Combination of Hydroquinone and Fractional CO(2) Laser versus Hydroquinone Monotherapy in Melasma Treatment: A Randomized, Single-blinded. Split-face Clinical Trial Indian J Dermatol 64(2):129\u201335. https:\/\/doi.org\/10.4103\/ijd.IJD_240_17","journal-title":"Split-face Clinical Trial Indian J Dermatol"},{"issue":"4","key":"3972_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/jocd.13992","volume":"20","author":"Y Qu","year":"2021","unstructured":"Qu Y, Wang F, Liu J et al (2021) Clinical observation and dermoscopy evaluation of fractional CO(2) laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol 20(4):1110\u20136. https:\/\/doi.org\/10.1111\/jocd.13992","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"3972_CR15","first-page":"61","volume":"14","author":"E Elmorsy","year":"2021","unstructured":"Elmorsy E, Aboukhadr N, Tayyeb M et al (2021) Low-power Fractional Carbon Dioxide Laser Followed by Jessner\u2019s Peel versus Jessner\u2019s Peel Alone for the Treatment of Melasma. J Clin Aesthet Dermatol 14(2):61\u20137","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"3972_CR16","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/jocd.13537","volume":"20","author":"KMM Mekawy","year":"2021","unstructured":"Mekawy KMM, Sadek A, Seddeik Abdel-Hameed AK (2021) Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study. J Cosmet Dermatol 20(2):460\u20135. https:\/\/doi.org\/10.1111\/jocd.13537","journal-title":"J Cosmet Dermatol"},{"issue":"10","key":"3972_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/lsm.23441","volume":"53","author":"S Esmat","year":"2021","unstructured":"Esmat S, Elramly AZ, Shahin D, Hilal RF et al (2021) Combining Low Power Fractional CO(2) With QS-NdYAG Toning in the Treatment of Melasma Reduces the Incidence of Punctate Leukoderma. Lasers Surg Med 53(10):1325\u201340. https:\/\/doi.org\/10.1002\/lsm.23441","journal-title":"Lasers Surg Med"},{"issue":"5","key":"3972_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/dss.0000000000003423","volume":"48","author":"SO Tawfic","year":"2022","unstructured":"Tawfic SO, Abdel Hay RM, Abouelazm DI et al (2022) Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment: A Dermoscopic Evaluation. Dermatol Surg. 48(5):556\u201361. https:\/\/doi.org\/10.1097\/dss.0000000000003423","journal-title":"Dermatol Surg."},{"issue":"1","key":"3972_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15171\/jlms.2017.01","volume":"8","author":"S Alavi","year":"2017","unstructured":"Alavi S, Abolhasani E, Asadi S et al (2017) Combination of Q-Switched Nd:YAG and Fractional Erbium:YAG Lasers in Treatment of Melasma: A Randomized Controlled Clinical Trial. J Lasers Med Sci 8(1):1\u20136. https:\/\/doi.org\/10.15171\/jlms.2017.01","journal-title":"J Lasers Med Sci"},{"key":"3972_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/ccid.s147413","volume":"11","author":"AM Badawi","year":"2018","unstructured":"Badawi AM, Osman MA (2018) Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol 11:13\u201320. https:\/\/doi.org\/10.2147\/ccid.s147413","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"3972_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14764172.2019.1605447","volume":"21","author":"S Garg","year":"2019","unstructured":"Garg S, Vashisht KR, Makadia S (2019) A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature. J Cosmet Laser Ther 21(5):297\u2013307. https:\/\/doi.org\/10.1080\/14764172.2019.1605447","journal-title":"J Cosmet Laser Ther"},{"issue":"3\u20134","key":"3972_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/14764172.2021.1964536","volume":"23","author":"MA Al-Dhalimi","year":"2021","unstructured":"Al-Dhalimi MA, Yasser RH (2021) Evaluation of the of the efficacy of Fractional Erbium-Doped Yttrium Aluminum Garnet Laser-Assisted Drug Delivery of Kojic Acid in the Treatment of Melasma; A split face, comparative clinical study. J Cosmet Laser Ther 23(3\u20134):65\u201371. https:\/\/doi.org\/10.1080\/14764172.2021.1964536","journal-title":"J Cosmet Laser Ther"},{"issue":"8","key":"3972_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00403-021-02294-z","volume":"314","author":"M Nasimi","year":"2022","unstructured":"Nasimi M, Ghiasi M, Lajevardi V et al (2022) A split-face comparison of fractional erbium: YAG laser plus Kligman\u2019s formula vs Kligman\u2019s formula monotherapy for facial melasma. Arch Dermatol Res 314(8):791\u20137","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"3972_CR24","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1080\/09546634.2021.1968996","volume":"33","author":"F Mokhtari","year":"2022","unstructured":"Mokhtari F, Bahrami B, Faghihi G et al (2022) Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial. J Dermatolog Treat 33(5):2475\u201381. https:\/\/doi.org\/10.1080\/09546634.2021.1968996","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"3972_CR25","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1080\/09546634.2021.1914313","volume":"33","author":"N Neagu","year":"2022","unstructured":"Neagu N, Conforti C, Agozzino M et al (2022) Melasma treatment: a systematic review. J Dermatolog Treat 33(4):1816\u201337. https:\/\/doi.org\/10.1080\/09546634.2021.1914313","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"3972_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/jocd.12751","volume":"18","author":"H Abdel-Raouf Mohamed","year":"2019","unstructured":"Abdel-Raouf Mohamed H, Ali Nasif G, Saad Abdel-Azim E et al (2019) Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmet Dermatol 18(2):517\u201323. https:\/\/doi.org\/10.1111\/jocd.12751","journal-title":"J Cosmet Dermatol"},{"issue":"4\u20135","key":"3972_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/01913123.2019.1673861","volume":"43","author":"ZG El-Sinbawy","year":"2019","unstructured":"El-Sinbawy ZG, Abdelnabi NM, Sarhan NE et al (2019) Clinical & ultrastructural evaluation of the effect of fractional CO2 laser on facial melasma. Ultrastructural pathology 43(4\u20135):135\u201344. https:\/\/doi.org\/10.1080\/01913123.2019.1673861","journal-title":"Ultrastructural pathology"},{"issue":"9","key":"3972_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/17425247.2019.1649655","volume":"16","author":"CY Hsiao","year":"2019","unstructured":"Hsiao CY, Yang SC, Alalaiwe A et al (2019) Laser ablation and topical drug delivery: a review of recent advances. Expert Opinion Drug Delivery 16(9):937\u201352. https:\/\/doi.org\/10.1080\/17425247.2019.1649655","journal-title":"Expert Opinion Drug Delivery"},{"issue":"4","key":"3972_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40257-017-0333-6","volume":"19","author":"BP Kaufman","year":"2018","unstructured":"Kaufman BP, Aman T, Alexis AF (2018) Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment. Am J Clin Dermatol. 19(4):489\u2013503. https:\/\/doi.org\/10.1007\/s40257-017-0333-6","journal-title":"Am J Clin Dermatol."},{"issue":"2","key":"3972_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/14764172.2015.1063662","volume":"18","author":"WC Tian","year":"2016","unstructured":"Tian WC (2016) Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser. J Cosmet Laser Ther 18(2):72\u20134. https:\/\/doi.org\/10.3109\/14764172.2015.1063662","journal-title":"J Cosmet Laser Ther"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-03972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-024-03972-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-03972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:40:35Z","timestamp":1738338035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-024-03972-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3972"],"URL":"https:\/\/doi.org\/10.1007\/s10103-024-03972-w","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not include any human subjects.Informed consentNone.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"71"}}